Form 4: Marimed CEO Levine Converts RSUs, Covers Taxes
Insider Transaction Report
Marimed Inc.'s President and CEO, Jon R. Levine, converted 138,888 Restricted Stock Units into common stock and simultaneously disposed of 40,764 shares to cover tax obligations.
Summary
- Jon R. Levine, President and CEO, Director, and 10% Owner of Marimed Inc. (MRMD), reported changes in his beneficial ownership.
- On October 27, 2025, Mr. Levine acquired 138,888 shares of common stock through the conversion of Restricted Stock Units (RSUs).
- These RSUs converted on a one-for-one basis and were granted on October 27, 2022, with no unvested RSUs remaining from this grant.
- Concurrently, 40,764 shares of common stock were disposed of at a price of $0.1579 per share to satisfy tax withholding obligations related to the RSU vesting.
- Following these transactions, Mr. Levine directly beneficially owns 20,953,494 shares of common stock.
- Additionally, 6,684,640 shares are indirectly beneficially owned through the Jon Levine Family Trust, for which Mr. Levine disclaims beneficial ownership.
Sentiment
Score: 6
Explanation: The filing reflects a routine insider transaction involving the vesting of equity compensation and subsequent tax withholding. This is generally neutral, with a slight positive tilt due to the executive's continued equity alignment.
Positives
- The vesting of 138,888 Restricted Stock Units indicates the successful fulfillment of equity compensation terms for a key executive.
- The conversion of RSUs into common stock increases the direct shareholding of the CEO, aligning his interests with those of other shareholders.
Negatives
- A disposition of 40,764 shares, even for tax withholding purposes, results in a reduction of the CEO's direct share count.
Stakeholder Impact
- Shareholders: The transaction is a routine insider ownership change and is unlikely to have a significant direct impact on shareholders, beyond transparency into executive compensation.
Key Dates
| Date | Description |
|---|---|
| 10/27/2022 | Grant date of the Restricted Stock Units (RSUs) to Jon R. Levine. |
| 10/27/2025 | Date of RSU conversion into common stock and subsequent tax withholding transaction. |
Keywords
Marimed Inc., MRMD, Jon R. Levine, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Conversion, Tax Withholding, Beneficial Ownership, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.